Subject: New Drug Names



Marijuana

List of Controlled Substances

Lists of Scheduling Actions, Controlled Substances, Regulated Chemicals (PDF) (December 2020)

This document is a general reference and not a comprehensive list. This list describes the basic or parent chemical and does not describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be controlled substances.

A drug already approved by the Licensing Authority mentioned in Rule 21 for certain claims, which is now proposed to be marketed with modified or new claims, namely, indications, dosage, dosage form (including sustained release dosage form) and route of administration. Fixed dose combination of two or more drugs, individually approved earlier. Drug names are often subject to legal regulation, including approval for new drugs (to avoid confusion with existing drugs) and on packaging to establish clear rules about adulterants and fraudulent or misleading labeling. A national formulary is often designated to define drug names (and purity standards) for regulatory purposes. The drug is subject to an open drug efficacy study implementation (DESI) program proceeding, health care professionals rely on the drug to treat serious medical conditions when there is no FDA.

List of Drugs A-Z tool - Find drug information on prescription drugs, medicines & supplements including side effects, drug interactions & generic drug name. Drugs on our Preventive Drug List are not subject to the deductible with most CDPHP high deductible plans. The Preventive Drug List & High Deductible Plans 123 While high deductibles may give members more control over their health care dollars, they can also make some members hesitant to maintain the preventive medications that are sometimes.

Scheduling ActionsControlled SubstancesList I and II Regulated Chemicals
Alphabetical OrderAlphabetical OrderAlphabetical Order
Chronological OrderDEA Drug Code NumberDEA Number
CSA ScheduleList Number
Illicit Uses and Threshold Quantities

Exempted Lists

Exempt Anabolic Steroid Products

Exempt Anabolic Steroid Products Procedures

Exempt Anabolic Steroid Products List (PDF) (November 5, 2020)

New

Exempt Chemical Preparations

Exempt Chemical Preparations List (PDF) (November 7, 2017) For Application Dates Through December 31, 2016

Exempted Prescription Products

Exempted Prescription Products Application

Exempted Prescription Products List (PDF) (January 11, 2021)

Lists of Controlled Substances Disclaimer

Section 812 of the Controlled Substances Act (21 U.S.C. §801 et seq.) (CSA) lists substances which were controlled in 1970 when the CSA was enacted. Since then many substances have been added, removed, or transferred from one schedule to another. The current list of controlled substances can be found in section 1308 of the most recent issue of Title 21 Code of Federal Regulations (CFR) Part 1300 to end (21 CFR §1308) and the final rules which were published in the Federal Register subsequent to the issuance of the CFR.

These lists describe the basic or parent chemical and do not describe the salts, isomers, salts of isomers, esters, ethers, and derivatives which may be controlled substances. These are not comprehensive lists so please note that a substance need not be listed as a controlled substance to be treated as a scheduled substance for criminal prosecution. The 'Other Names' column, provides some examples of alternate names for certain compounds, and in some instances provides examples of 'positional isomers'. If outside parties want to ensure that a compound is not considered a scheduled substance or listed chemical, they should write the DEA, Drug and Chemical Evaluation Section (DRE), Diversion Control Division, 8701 Morrissette Drive, Springfield, Virginia 22152, for an official determination.

A substance (not included on these lists) may also be regulated as a controlled substance analogue. A controlled substance analogue is a substance which is intended for human consumption, is structurally substantially similar to a schedule I or schedule II substance, is pharmacologically substantially similar to a schedule I or schedule II substance, or is represented as being similar to a schedule I or schedule II substance and is not an approved medication in the United States. See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.

Defined Abbreviations

Defined
Abbreviation
Controlled Substance Analogue
2C-B4-Bromo-2,5-dimethoxyphenethylamine
2C-T-72,5-Dimethoxy-4(n)-propylthiophenethylamine
BZPN-Benzylpiperazine
DMTDimethyltryptamine
DOM4-Methyl-2,5-dimethoxyamphetamine
GBLGamma butyrolactone
GHBGamma hydroxybutyric acid, gamma hydroxybutyrate, 4-hydroxybutanoic acid, sodium oxybate
LAAMLevo-alphacetylmethadol
LSDLysergic acid diethylamide, lysergide
MDA3,4-Methylenedioxyamphetamine
MDE3,4-Methylenedioxy-N-ethylamphetamine
MDMA3,4-Methylenedioxymethamphetamine
MPPP1-Methyl-4-phenyl-4-propionoxypiperidine
P2PPhenyl-2-propanone, phenylacetone
PCC1-Piperidinocyclohexanecarbonitrile
PCEN-Ethyl-1-phenylcyclohexylamine
PCH1-Phenylcyclohexylamine
PCP1-(1-Phenylcyclohexyl)piperidine, phencyclidine
PEPAP1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
PHP1-(1-Phenylcyclohexyl)pyrrolidine
SPA(-)-1-Dimethylamino-1,2-diphenylethane
TCP1-[1-(2-Thienyl)cyclohexyl]piperidine
TCPy1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
THCTetrahydrocannabinols
THGTetrahydrogestrinone

Definition of Controlled Substance Schedules

Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are divided into five schedules. An updated and complete list of the schedules is published annually in Title 21 Code of Federal Regulations (C.F.R.) §§1308.11 through 1308.15. Substances are placed in their respective schedules based on whether they have a currently accepted medical use in treatment in the United States, their relative abuse potential, and likelihood of causing dependence when abused. Some examples of the drugs in each schedule are listed below.

Schedule I Controlled Substances

Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.

Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ('Ecstasy').

Schedule II/IIN Controlled Substances (2/2N)

Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.

Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone.

Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®).

Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital.

Schedule III/IIIN Controlled Substances (3/3N)

Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.

Subject: New Drug Names Generic

Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®).

Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone.

Schedule IV Controlled Substances

Substances in this schedule have a low potential for abuse relative to substances in Schedule III.

Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®).

Schedule V Controlled Substances

Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics.

Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.

Search by Drug Name, Active Ingredient, or Application Number*

About Drugs@FDA | FAQ | Glossary | Contact Us
* Drugs@FDA includes information about drugs, including biological products, approved for human use in the United States (see FAQ), but does not include information about FDA-approved products regulated by the Center for Biologics Evaluation and Research (for example, vaccines, allergenic products, blood and blood products, plasma derivatives, cellular and gene therapy products). For prescription brand-name drugs, Drugs@FDA typically includes the most recent labeling

Subject: New Drug Names A-z

approved

Subject: New Drug Names Meanings

by the FDA (for example, Prescribing Information and FDA-approved patient labeling when available), regulatory information, and FDA staff reviews that evaluate the safety and effectiveness of the drug.